Medigen Biotechnology Market Cap

Medigen Biotechnology has a market cap or net worth of 4.97 billion as of February 21, 2025. Its market cap has decreased by -17.95% in one year.

Market Cap

4.97B

Enterprise Value

6.93B

Revenue

1.41B

Ranking

n/a

PE Ratio

n/a

Stock Price

35.70

Market Cap Chart

Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.97B, an increase of 626.49%. That is a compound annual growth rate of 10.25%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	4.97B	10.19%
Dec 31, 2024	4.51B	-27.70%
Dec 29, 2023	6.24B	33.24%
Dec 30, 2022	4.69B	-41.43%
Dec 30, 2021	8.00B	-2.78%
Dec 31, 2020	8.23B	-4.46%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	209.72B
Caliway Biopharmaceuticals	142.08B
Bora Pharmaceuticals Co., LTD.	89.70B
Lotus Pharmaceutical	71.91B
Lumosa Therapeutics	39.78B
Oneness Biotech	38.63B
Polaris Group	36.08B
Pegavision	30.65B

Market Cap Rankings